Median CD4 count was the lowest in germinal tumors (117 cells/μL) and the highest in women with breast cancer (890 cells/μL); median viral load was < 40 copies/mL in nearly all patients with neoplasms, except for germinal and head-and neck-tumors. Here, CD4 is linked to breast cancer.